| Financial Year |
March 31 2023 |
| Monetary Funds |
327,380,435.21 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
18,060,000.00 |
| Accounts Receivable |
2,725,161,876.21 |
| Advances to Suppliers |
12,978,836.83 |
| Other Receivables |
137,792,520.18 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
185,542,873.37 |
| Total Current Assets |
3,785,214,159.80 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
5,718,207.26 |
| Long-term Equity Investment |
264,284,157.83 |
| Investment Properties |
-- |
| Fixed Assetes |
8,893,878,485.90 |
| Under-construction Projects |
1,113,991,067.06 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,588,419,936.71 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
758,722.09 |
| Deferred Income Tax Assets |
133,190,590.32 |
| Other Non-Current Assets |
564,721,286.68 |
| Sub-Total of Non-Current Assets |
15,092,145,738.94 |
| Total Assets |
18,877,359,898.74 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,221,539,113.55 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,144,744.51 |
| Taxes Payable |
91,213,618.82 |
| Interest Payable |
-- |
| Dividend Payable |
29,121,270.40 |
| Other payables |
135,464,742.20 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
475,015,015.27 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
2,281,331,457.62 |
| Long-term Loans |
3,307,067,648.00 |
| Bonds Payable |
258,189,357.04 |
| Long-Term Accounts Payable |
4,583,507,790.96 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
309,906,585.89 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
10,617,980,249.81 |
| Total Liabilities |
12,899,311,707.42 |
| Paid-In Capital(Or Share Stock) |
2,434,312,419.00 |
| Capital Surplus |
1,521,254,970.10 |
| Surplus Reserve |
227,737,421.92 |
| LESS:Treasury Stock |
65,482,560.00 |
| Undistributed Profits |
1,886,838,746.56 |
| Minority Stockholder's Interest |
-88,060,059.56 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,066,108,250.88 |
| Owner's Equity（Stockholder's Equity） |
5,978,048,191.32 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
18,877,359,898.74 |
